Prefrontal cortical and striatal transcriptional responses to the reinforcing effect of repeated methylphenidate treatment in the spontaneously hypertensive rat, animal model of attention-deficit/hyperactivity disorder (ADHD)

[1]  Bung-Nyun Kim,et al.  Prefrontal cortical and striatal transcriptional responses to the reinforcing effect of repeated methylphenidate treatment in the spontaneously hypertensive rat, animal model of attention-deficit/hyperactivity disorder (ADHD) , 2014, Behavioral and Brain Functions.

[2]  J. Cheong,et al.  Neuronal development genes are key elements mediating the reinforcing effects of methamphetamine, amphetamine, and methylphenidate , 2013, Psychopharmacology.

[3]  J. Cheong,et al.  Abuse and dependence liability analysis of methylphenidate in the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder (ADHD): what have we learned? , 2013, Archives of pharmacal research.

[4]  P. Poronnik,et al.  Nedd4 and Nedd4-2: ubiquitin ligases at work in the neuron. , 2013, The international journal of biochemistry & cell biology.

[5]  H. Steiner,et al.  Addiction-related gene regulation: Risks of exposure to cognitive enhancers vs. other psychostimulants , 2013, Progress in Neurobiology.

[6]  C. Wiley,et al.  Psychostimulant Abuse and Neuroinflammation: Emerging Evidence of Their Interconnection , 2013, Neurotoxicity Research.

[7]  J. Cheong,et al.  Differential behavioral responses of the spontaneously hypertensive rat to methylphenidate and methamphetamine: lack of a rewarding effect of repeated methylphenidate treatment , 2012, Neuroscience Letters.

[8]  Chunxu Qu,et al.  Methylphenidate Exposure Induces Dopamine Neuron Loss and Activation of Microglia in the Basal Ganglia of Mice , 2012, PloS one.

[9]  E. Hess,et al.  Rodent models of ADHD. , 2012, Current topics in behavioral neurosciences.

[10]  A. Wyse,et al.  Chronic methylphenidate administration alters antioxidant defenses and butyrylcholinesterase activity in blood of juvenile rats , 2012, Molecular and Cellular Biochemistry.

[11]  E. Nestler,et al.  Transcriptional and epigenetic mechanisms of addiction , 2011, Nature Reviews Neuroscience.

[12]  R. Canese,et al.  Neurobehavioral adaptations to methylphenidate: The issue of early adolescent exposure , 2011, Neuroscience & Biobehavioral Reviews.

[13]  N. Volkow,et al.  New medications for drug addiction hiding in glutamatergic neuroplasticity , 2011, Molecular Psychiatry.

[14]  L. Dwoskin,et al.  Methylphenidate Treatment in Adolescent Rats with an Attention Deficit/Hyperactivity Disorder Phenotype: Cocaine Addiction Vulnerability and Dopamine Transporter Function , 2011, Neuropsychopharmacology.

[15]  J. Cheong,et al.  Methylphenidate self-administration and conditioned place preference in an animal model of attention-deficit hyperactivity disorder: the spontaneously hypertensive rat , 2011, Behavioural pharmacology.

[16]  N. Volkow,et al.  Neurocircuitry of Addiction , 2010, Neuropsychopharmacology.

[17]  F. Fumagalli,et al.  Sub-chronic exposure to atomoxetine up-regulates BDNF expression and signalling in the brain of adolescent spontaneously hypertensive rats: comparison with methylphenidate. , 2010, Pharmacological research.

[18]  C. Matté,et al.  Methylphenidate affects memory, brain-derived neurotrophic factor immunocontent and brain acetylcholinesterase activity in the rat , 2010, Neurobiology of Learning and Memory.

[19]  Min Zhang,et al.  Gene expression profiles in the prefrontal cortex of SHR rats by cDNA microarrays , 2010, Molecular Biology Reports.

[20]  J. Quevedo,et al.  Inhibition of Mitochondrial Respiratory Chain in the Brain of Adult Rats After Acute and Chronic Administration of Methylphenidate , 2010, Neurochemical Research.

[21]  Melinda E. Lull,et al.  Gene expression changes in the medial prefrontal cortex and nucleus accumbens following abstinence from cocaine self-administration , 2010, BMC Neuroscience.

[22]  S. Cheetham,et al.  The neuropharmacology of ADHD drugs in vivo: Insights on efficacy and safety , 2009, Neuropharmacology.

[23]  G. Réus,et al.  Superoxide production after acute and chronic treatment with methylphenidate in young and adult rats , 2009, Neuroscience Letters.

[24]  J. Quevedo,et al.  Methylphenidate treatment increases Na+, K+-ATPase activity in the cerebrum of young and adult rats , 2009, Journal of Neural Transmission.

[25]  L. Vendruscolo,et al.  Drug reinforcement in a rat model of attention deficit/hyperactivity disorder--the Spontaneously Hypertensive Rat (SHR). , 2009, Current drug abuse reviews.

[26]  S. Kollins.  ADHD, Substance Use Disorders, and Psychostimulant Treatment , 2008, Journal of attention disorders.

[27]  V. Russell,et al.  Methylphenidate does not increase ethanol consumption in a rat model for attention-deficit hyperactivity disorder—the spontaneously hypertensive rat , 2008, Metabolic Brain Disease.

[28]  Eric M. Morrow,et al.  Identifying Autism Loci and Genes by Tracing Recent Shared Ancestry , 2008, Science.

[29]  F. Castellanos,et al.  Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood. , 2008, The American journal of psychiatry.

[30]  S. Kollins.  A qualitative review of issues arising in the use of psychostimulant medications in patients with ADHD and co‑morbid substance use disorders , 2008, Current medical research and opinion.

[31]  T. Yagi.  Clustered protocadherin family , 2008, Development, growth & differentiation.

[32]  T. Lehtimäki,et al.  Behavioral and Brain Functions , 2008 .

[33]  S. Kollins.  A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders. , 2008, Current medical research and opinion.

[34]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[35]  M. Takeichi,et al.  OL-protocadherin is essential for growth of striatal axons and thalamocortical projections , 2007, Nature Neuroscience.

[36]  M. Wilkinson,et al.  Methylphenidate regulates activity regulated cytoskeletal associated but not brain-derived neurotrophic factor gene expression in the developing rat striatum , 2007, Neuroscience.

[37]  R. Harlan,et al.  Drugs of abuse and immediate-early genes in the forebrain , 1998, Molecular Neurobiology.

[38]  Jun-Feng Wang,et al.  Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder. , 2006, Journal of psychiatry & neuroscience : JPN.

[39]  S. Kourrich,et al.  Differential behavioral and neurochemical effects of cocaine after early exposure to methylphenidate in an animal model of attention deficit hyperactivity disorder , 2006, Behavioural Brain Research.

[40]  V. Russell,et al.  Animal models of attention-deficit hyperactivity disorder , 2005, Behavioral and Brain Functions.

[41]  Mehdi Farshbaf,et al.  Rodent Models of Attention-Deficit/Hyperactivity Disorder , 2005, Biological Psychiatry.

[42]  E. Butelman,et al.  Microarray Studies of Psychostimulant‐Induced Changes in Gene Expression , 2005, Addiction biology.

[43]  T. Robbins,et al.  Cognitive Sequelae of Intravenous Amphetamine Self-Administration in Rats: Evidence for Selective Effects on Attentional Performance , 2005, Neuropsychopharmacology.

[44]  J. Crabbe,et al.  Gene expression induced by drugs of abuse. , 2005, Current opinion in pharmacology.

[45]  M. Marinelli,et al.  Adolescent exposure to methylphenidate alters the activity of rat midbrain dopamine neurons , 2003, Biological Psychiatry.

[46]  Nora D Volkow,et al.  Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. , 2003, The American journal of psychiatry.

[47]  S. Yui,et al.  Calprotectin (S100A8/S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity. , 2003, Biological & pharmaceutical bulletin.

[48]  David M. Lovinger,et al.  It could be habit forming: drugs of abuse and striatal synaptic plasticity , 2003, Trends in Neurosciences.

[49]  F. Tarazi,et al.  Animal models of attention-deficit hyperactivity disorder , 2003, Brain Research Reviews.

[50]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[51]  J Lowe,et al.  The ubiquitin protein catabolic disorders , 2001, Neuropathology and applied neurobiology.

[52]  N. Volkow,et al.  Comparison between intraperitoneal and oral methylphenidate administration: A microdialysis and locomotor activity study. , 2000, The Journal of pharmacology and experimental therapeutics.

[53]  C. Pickart,et al.  Inhibition of the ubiquitin-proteasome system in Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[54]  S. Hyman,et al.  Addiction, Dopamine, and the Molecular Mechanisms of Memory , 2000, Neuron.

[55]  Terje Sagvolden,et al.  Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD) , 2000, Neuroscience & Biobehavioral Reviews.

[56]  N. Volkow,et al.  Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D(2) receptors. , 1999, The Journal of pharmacology and experimental therapeutics.

[57]  P. Fletcher,et al.  Depletion of brain serotonin following intra-raphe injections , 1999, Psychopharmacology.

[58]  M. Solanto.  Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration , 1998, Behavioural Brain Research.

[59]  S. Faraone,et al.  Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study. , 2003, Journal of the American Academy of Child and Adolescent Psychiatry.

[60]  M. Zigmond,et al.  Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[61]  G. Rebec,et al.  Dopaminergic modulation of glutamate-induced excitations of neurons in the neostriatum and nucleus accumbens of awake, unrestrained rats. , 1996, Journal of neurophysiology.

[62]  K. Berridge,et al.  The neural basis of drug craving: An incentive-sensitization theory of addiction , 1993, Brain Research Reviews.

[63]  M. Colado,et al.  Striatal dopamine release in vivo following neurotoxic doses of methamphetamine and effect of the neuroprotective drugs, chlormethiazole and dizocilpine , 1993, British journal of pharmacology.

[64]  J. Townsend,et al.  Pre- and Postsynaptic Neurotoxic Effects of Dopamine Demonstrated by Intrastriatal Injection , 1993, Experimental Neurology.